Finance

Lists
OWLT:NYSE
Owlet Inc
$4.74
+4.41%
(+0.20) 1D
$4.74
0.00% (0.00)
After hours
Closed: Sep 18, 4:00:10 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OWLT...
Open
$4.53
High
$4.78
Low
$4.48
Mkt. cap
138.51M
Avg. vol.
239.83K
Volume
546.12K
52-wk high
$16.94
52-wk low
$4.19
EPS
-$0.46
Beta
1.90
Shares outstanding
29.22M
No. of employees
111
Open
$4.53
High
$4.78
Low
$4.48
Mkt. cap
138.51M
Avg. vol.
239.83K
Volume
546.12K
52-wk high
$16.94
52-wk low
$4.19
EPS
-$0.46
Beta
1.90
Shares outstanding
29.22M
No. of employees
111
News stories
From web sources and news partners
About Owlet Inc
CEO-
Employees111
Founded2013
Headquarters-
SectorMedical device
Websiteowletcare.com
Analyst ratings
Based on 4 analysts giving stock ratings to OWLT in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OWLT in the last 3 months.
Highest
Current $4.74
$14.00 (+195.36%)
Average
$12.33 (+160.13%)
Lowest
$10.00 (+110.97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Owen Rickert
Northland Securities
Buy
Maintained
$13.00
+174.3%
09/10/2026
Jonna Kim
TD Cowen
Buy
Reiterated
$10.00
+111%
08/13/2026
Steven Lichtman
William Blair
Buy
Maintained
-
-
08/12/2026
Ben Haynor
Lake Street
Buy
Reiterated
$14.00
+195.4%
08/10/2026
Oliver Chen
TD Cowen
Buy
Reiterated
$10.00
+111%
06/22/2026
Andrew Brackmann
William Blair
Buy
Reiterated
-
-
05/08/2026
Last report
Aug 11, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.20 / -$0.02
+900.00%beat
Revenue / Est. (USD)
33.86M / 31.72M
+6.76%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
31.99M
26.55M
22.46M
33.86M
Cost of goods sold
15.79M
13.93M
10.22M
12.04M
Cost of revenue
15.79M
13.93M
10.22M
12.04M
Research and development expenses
3.78M
3.64M
3.96M
4.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.20M
13.88M
13.77M
15.52M
Operating expense
14.98M
17.51M
17.73M
20.08M
Total operating expenses
30.77M
31.44M
27.95M
32.12M
Operating income
1.22M
-4.89M
-5.49M
1.74M
Other non operating income
3.79M
-3.74M
2.85M
566.00K
EBT including unusual items
4.14M
-9.22M
-3.33M
-610.00K
EBT excluding unusual items
4.14M
-9.22M
-3.33M
1.60M
Income tax expense
9.00K
-26.00K
7.00K
10.00K
Effective tax rate
0.22%
0.28%
-0.21%
-1.64%
Other operating expenses
-
-
-
-
Net income
4.13M
-9.19M
-3.34M
-620.00K
Net profit margin
12.92%
-34.61%
-14.86%
-1.83%
Earnings per share
0.03
-0.03
-0.09
0.20
Interest and investment income
-
-
-
-
Interest expense
-860.00K
-588.00K
-683.00K
-707.00K
Net interest expenses
-860.00K
-588.00K
-683.00K
-707.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
1.27M
-4.83M
-5.43M
1.81M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps